Concern is rising about the COVID-19 variants BA.2.86 and EG.5 as the United States is seeing a surge in COVID-19 cases and hospitalizations. Now, the FDA has approved a new COVID-19 booster that targets the XBB.1.5 Omicron subvariant. Dr. Stuart Cohen, chief of infectious diseases at UC Davis Health, answers questions about the new booster, why it is a monovalent vaccine and who should consider getting it.
Read more about the new COVID-19 vaccine booster and new variants: https://health.ucdavis.edu/news/headlines/ba286-and-eg5-how-will-the-new-covid-19-boosters-work-with-new-variants-/2023/09
See the latest news from UC Davis Health: https://health.ucdavis.edu/newsroom
0:00 Why is a new COVID-19 booster needed?
0:30 Will the booster protect against new variants?
1:11 Why is the new booster a monovalent vaccine?
2:16 Who should get the new COVID-19 booster?
3:25 Should you get the vaccine if you’ve recently had COVID?
#covid #covid19 #boostershots #vaccine #covidvaccine #ucdavis
